<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Молодежный инновационный вестник</journal-id><journal-title-group><journal-title>Молодежный инновационный вестник</journal-title></journal-title-group><issn publication-format="print">2415-7805</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">8875</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>THE ROLE OF E-CADHERIN IN THE PROGNOSIS OF THYROID CANCER RECURRENCE</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Atadzhanov</surname><given-names>Ilyas Borisovich</given-names></name><email>atadzanov.ilyas@yandex.ru</email><uri content-type="orcid">https://orcid.org/0000-0003-1995-2661</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shestakova</surname><given-names>Valeriya Gennadievna</given-names></name><email>shestvg@mail.ru</email><uri content-type="orcid">https://orcid.org/0000-0003-1136-7396</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nigmatullina</surname><given-names>Leila Ildarovna</given-names></name><email>leila.nigmatullina@gmail.com</email><uri content-type="orcid">https://orcid.org/0000-0002-1598-9638</uri><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Tver State Medical University</aff><pub-date date-type="epub" iso-8601-date="2023-03-29" publication-format="electronic"><day>29</day><month>03</month><year>2023</year></pub-date><volume>12</volume><issue>1</issue><fpage>11</fpage><lpage>12</lpage><history><pub-date date-type="received" iso-8601-date="2023-04-17"><day>17</day><month>04</month><year>2023</year></pub-date><pub-date date-type="accepted" iso-8601-date="2023-06-04"><day>04</day><month>06</month><year>2023</year></pub-date></history><permissions><copyright-statement>Copyright © 2023, Atadzhanov I.B., Shestakova V.G., Nigmatullina L.I.</copyright-statement><copyright-year>2023</copyright-year></permissions><abstract>&lt;p style="text-align: justify;"&gt;The aim of the study was to clarify the role of E-cadherin expression in thyroid tumor tissue samples and to determine the possibility of making a prognosis for cancer recurrence. Materials and methods. Human tumor tissue samples were examined by histological and immunohistochemical methods. Results. A significant decrease in the expression of E-cadherin was found in 1/3 of cases of papillary thyroid cancer. The preservation of E-cadherin expression in follicular cancer has also been established.&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>thyroid</kwd><kwd>cancer</kwd><kwd>histology</kwd><kwd>immunohistochemistry</kwd><kwd>E-cadherin</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>щитовидная железа</kwd><kwd>рак</kwd><kwd>гистология</kwd><kwd>иммуногистохимия</kwd><kwd>Е-кадгерин</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Shah JP. Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3-6</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Li Z, Yin S, Zhang L, Liu W, Chen B. Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis. Oncotarget. 2017 Mar 7;8(10):16445-16455</mixed-citation></ref></ref-list></back></article>
